Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.

Source:http://linkedlifedata.com/resource/pubmed/id/15121021

Download in:

View as

General Info

PMID
15121021